12/23
04:14 pm
xoma
XOMA Royalty (NASDAQ:XOMA) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
XOMA Royalty (NASDAQ:XOMA) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
12/22
07:30 am
xoma
XOMA Royalty Declares Quarterly Preferred Stock Dividends
Low
Report
XOMA Royalty Declares Quarterly Preferred Stock Dividends
12/16
04:43 pm
xoma
XOMA Royalty (NASDAQ:XOMA) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
XOMA Royalty (NASDAQ:XOMA) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
12/12
01:05 pm
xoma
XOMA Royalty (NASDAQ:XOMA) was given a new $50.00 price target on by analysts at Stifel Nicolaus.
Low
Report
XOMA Royalty (NASDAQ:XOMA) was given a new $50.00 price target on by analysts at Stifel Nicolaus.
12/12
12:03 pm
xoma
XOMA Royalty (NASDAQ:XOMA) had its "buy" rating reaffirmed by analysts at Benchmark Co..
Low
Report
XOMA Royalty (NASDAQ:XOMA) had its "buy" rating reaffirmed by analysts at Benchmark Co..
12/11
12:01 pm
xoma
XOMA Royalty (NASDAQ:XOMA) was given a new $45.00 price target on by analysts at Leerink Partners.
Low
Report
XOMA Royalty (NASDAQ:XOMA) was given a new $45.00 price target on by analysts at Leerink Partners.
12/11
11:02 am
xoma
XOMA Royalty (NASDAQ:XOMA) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
XOMA Royalty (NASDAQ:XOMA) had its "buy" rating reaffirmed by analysts at HC Wainwright.
12/10
04:12 am
xoma
XOMA Royalty (NASDAQ:XOMA) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
XOMA Royalty (NASDAQ:XOMA) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
12/9
08:05 am
xoma
XOMA Royalty (NASDAQ:XOMA) was given a new $76.00 price target on by analysts at UBS Group AG.
Low
Report
XOMA Royalty (NASDAQ:XOMA) was given a new $76.00 price target on by analysts at UBS Group AG.
12/5
09:00 am
xoma
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
Medium
Report
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
11/26
02:24 pm
xoma
XOMA Royalty (NASDAQ:XOMA) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
XOMA Royalty (NASDAQ:XOMA) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
11/21
07:45 am
xoma
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
Medium
Report
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
11/20
06:03 am
xoma
XOMA Royalty (NASDAQ:XOMA) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Medium
Report
XOMA Royalty (NASDAQ:XOMA) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
11/14
01:19 pm
xoma
XOMA Royalty (NASDAQ:XOMA) was upgraded by analysts at
Weiss Ratings from a "sell (d-)" rating to a "hold (c-)" rating.
Low
Report
XOMA Royalty (NASDAQ:XOMA) was upgraded by analysts at
Weiss Ratings from a "sell (d-)" rating to a "hold (c-)" rating.
11/12
07:30 am
xoma
XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
Low
Report
XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
10/24
12:26 pm
xoma
XOMA Royalty (NASDAQ:XOMA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
XOMA Royalty (NASDAQ:XOMA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/22
12:25 pm
xoma
XOMA Royalty (NASDAQ:XOMA) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
XOMA Royalty (NASDAQ:XOMA) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
10/8
12:39 pm
xoma
XOMA Royalty (NASDAQ:XOMA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
XOMA Royalty (NASDAQ:XOMA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/3
03:48 pm
xoma
XOMA Royalty (NASDAQ:XOMA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
XOMA Royalty (NASDAQ:XOMA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.